Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands

被引:12
|
作者
Ishiwata, K
Kawamura, K
Kobayashi, T
Matsuno, K
机构
[1] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo 1730022, Japan
[2] SHI Accelerator Serv Co Ltd, Shinagawa Ku, Tokyo 1418686, Japan
[3] Ms Sci Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan
[4] Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma 6300101, Japan
关键词
haloperidol; sigma(1) receptor; dopamine D-2 receptor; C-11]SA4503; C-11]raclopride; positron emission tomography;
D O I
10.1016/S0969-8051(03)00003-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We investigated sigma, and dopamine D-2 receptor occupancy in mouse brain after a single injection of haloperidol, nemonapride, or spiperone using [C-11]SA4503 and [C-11]raclopride, respectively. Co-injection of the three compounds significantly blocked the uptake of each radioligand. Six hours later, only haloperidol blocked [C-11]SA4503 uptake, while all three reduced [C-11]raclopride uptake. Sigma(1) receptor occupancy by haloperidol was reduced to 19% at day 2 when D-2 receptor occupancy disappeared. [C-11]SA4503 would be applicable to the investigation of sigma, receptor occupancy of antispychotic drugs using PET. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 50 条
  • [31] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Blasiak, Ewa
    Lukasiewicz, Sylwia
    Szafran-Pilch, Kinga
    Dziedzicka-Wasylewska, Marta
    PHARMACOLOGICAL REPORTS, 2017, 69 (02) : 235 - 241
  • [32] Striatal dopamine D2 receptor occupancy in patients treated with olanzapine
    Raedler, TJ
    Knable, MB
    Lafargue, T
    Pickar, D
    Weinberger, DR
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 166 - 166
  • [33] Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain
    Turchan, J
    Lason, W
    Budziszewska, B
    Przewlocka, B
    NEUROPEPTIDES, 1997, 31 (01) : 24 - 28
  • [34] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Ewa Błasiak
    Sylwia Łukasiewicz
    Kinga Szafran-Pilch
    Marta Dziedzicka-Wasylewska
    Pharmacological Reports, 2017, 69 : 235 - 241
  • [35] Dopamine D2-like receptor signaling suppresses human osteoclastogenesis
    Hanami, Kentaro
    Nakano, Kazuhisa
    Saito, Kazuyoshi
    Okada, Yosuke
    Yamaoka, Kunihiro
    Kubo, Satoshi
    Kondo, Masahiro
    Tanaka, Yoshiya
    BONE, 2013, 56 (01) : 1 - 8
  • [36] Cloning and characterization of a Caenorhabditis elegans D2-like dopamine receptor
    Suo, S
    Sasagawa, N
    Ishiura, S
    JOURNAL OF NEUROCHEMISTRY, 2003, 86 (04) : 869 - 878
  • [37] Sila-haloperidol:: A silicon analogue of the dopamine (D2) receptor antagonist haloperidol
    Tacke, R
    Heinrich, T
    Bertermann, R
    Burschka, C
    Hamacher, A
    Kassack, MU
    ORGANOMETALLICS, 2004, 23 (19) : 4468 - 4477
  • [38] Dopamine D3 and D2 receptor occupancy of cariprazine in schizophrenic patients
    Potkin, S.
    Keator, D.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Gage, A.
    Xie, J.
    Ghahramani, P.
    Laszlovsky, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S316 - S316
  • [39] TIME COURSE OF D2-DOPAMINE RECEPTOR OCCUPANCY EXAMINED BY PET AFTER SINGLE ORAL DOSES OF HALOPERIDOL
    NORDSTROM, AL
    FARDE, L
    HALLDIN, C
    PSYCHOPHARMACOLOGY, 1992, 106 (04) : 433 - 438
  • [40] DOPAMINE D2 AND D3 RECEPTOR OCCUPANCY OF CARIPRAZINE IN SCHIZOPHRENIC PATIENTS
    Keator, David B.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Lakatos, A.
    Gage, A.
    Potkin, S. G.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 154 - 154